Quantifying the Burden of Diabetic Kidney Disease
Target Audience
Learning Objectives
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Link between T2D and kidney disease
- Unmet needs and rationale for emerging treatment options for DKD
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation
FACULTY
Professor of Medicine
Associate Dean for Clinical and Translational Research
University of Texas Southwestern Medical Center
Dallas, Texas
STEERING COMMITTEE MEMBER
Professor of Medicine
Director, AHA Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, Illinois, United States
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!